Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in biology …, 2020 - Elsevier
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …
被引用次数：97 相关文章

Multi-omits-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in Biology …, 2020 - hero.epa.gov
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …
[HTML] nih.gov

[HTML][HTML] Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in Biology …, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …

[引用][C] Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, V Azevedo, ME Weener… - Computers in Biology …, 2020 - elibrary.ru

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, M Weener, V Azevedo, A Góes-Neto… - 2021 - covid19.neicon.ru
< full-text-retrieval-response xmlns=" http://www. elsevier. com/xml/svapi/article/dtd" xmlns:
bk=" http://www. elsevier. com/xml/bk/dtd" xmlns: cals=" http://www. elsevier …

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh - 2021 - openrepository.ru
Antiviral agents, Nitric oxide, Photosensitizers, Viruses, Candidate drugs, Drug
combinations, Drug identification, Drug repositioning, Epstein-Barr virus, Integrated analysis …

[引用][C] Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in Biology …, 2020 - cir.nii.ac.jp
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against
COVID-19 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in Biology …, 2020 - europepmc.org
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo, A Góes-Neto… - 2020 - dl.acm.org
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener… - … in biology and …, 2020 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …